Tango Therapeutics' (TNGX) Sees Cautious Analyst Optimism Following Earnings
Financial firm Mizuho raised its share price target for Tango Therapeutics Inc. (NASDAQ:TNGX) on March 11th. It slightly adjusted the target to $20 from $19 and kept an Outperform rating on the stock.








